Gemfibrozil drug data and news

Gemfibrozil drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Gemfibrozil
Brand Names/Synonyms Apo-Gemfibrozil; Ausgem; Bolutol; Brozil; CCRIS 318; CHEMBANK796; CI 719; CI-719; Cholespid; Clearol; Decrelip; Elmogan; Fetinor; Fibratol; Fibrocit; GFZ; Gem-S; Gemd; Gemfibril; Gemfibromax; Gemfibrozil; Gemfibrozil [Usan:Ban:Inn]; Gemfibrozilo [Inn-Spanish]; Gemfibrozilum [Inn-Latin]; Gemlipid; Gemnpid; Gen-Fibro; Genlip; Gevilon; Gevilon Uno; Gozid; Hidil; Hipolixan; Innogen; Ipolipid; Jezil; Lanaterom; Lifibron; Lipazil; Lipigem; Lipira; Lipizyl; Lipozid; Lipur; Litarek; Lopid; Low-Lip; Micolip; Normolip; Novo-Gemfibrozil; Nu-Gemfibrozil; Pilder; Po-Gemfibrozil; Polyxit; Progemzal; Reducel; Regulip; Renabrazin; Sinelip; Synbrozil; TEVA-A; Taborcil; Tentroc; Trialmin; Uno; Wl-Gemfibrozil; [Usan:Ban:Inn]
Indication For treatment of adult patients with very high elevations of serum triglyceride levels (Types IV and V hyperlipidemia) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort
Sponsored links
Description Not Available
Pharmacology Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia.
Mechanism Of Action Gemfibrozil increases the activity of extrahepatic lipoprotein lipase (LL), thereby increasing lipoprotein triglyceride lipolysis. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL. This is accompanied by a slight increase in secretion of lipids into the bile and ultimately the intestine. Gemfibrozil also inhibits the synthesis and increases the clearance of apolipoprotein B, a carrier molecule for VLDL.
Gemfibrozil News
(When available)

The Lowdown on High Triglycerides  Feb 14, 2006
...you take niacin. Fibrates, which include gemfibrozil (Lopid) and fenofibrate (Tricor), are an alternative to niacin. They reduce ... - Gilroy Dispatch (subscription),

Statins may not affect CD4 cell count responses to HIV treatment ...  Feb 1, 2006
...they prescribed the 103 patients (39%) with raised triglyceride levels either bezafibrate (Bezalip), fenofibrate (Lipantil) or gemfibrozil (Lopid), while the ... - Aidsmap,

Traces of Prescription Drugs Found in Southland Aquifers  Jan 30, 2006
In waste that had undergone treatment, the antibiotic sulfamethoxazole and anti-cholesterol medication gemfibrozil were found at fairly high levels of around ... - Los Angeles Times,

Prescription drug traces found in recycled Los Angeles-area water  Jan 30, 2006
The antibiotic sulfamethoxazole and anti-cholesterol medication gemfibrozil were found in treated waste at fairly high levels of around one part per billion. ... - San Jose Mercury News,

Statins may not affect CD4 cell count responses to HIV treatment ...  Feb 1, 2006
...they prescribed the 103 patients (39%) with raised triglyceride levels either bezafibrate (Bezalip), fenofibrate (Lipantil) or gemfibrozil (Lopid), while the ... - Aidsmap,

'Working poor' join ranks of uninsured  Jan 18, 2006
His monthly supply of blood-pressure medicine, Lisinopril, costs $7. He pays $12 for a 30-day supply of cholesterol medication, Gemfibrozil. ... - AZ Central.com,

New weight-loss drug expected soon  Jan 9, 2006
...or Tricor. Generic compounds like cholestyramine, gemfibrozil and niacin offer cost-effective cholesterol control. The nutrient ... - Charlotte Observer,

Merck/Schering-Plough Announces Update for the IMPROVE-IT Trial  Nov 15, 2005
Gemfibrozil: In a study of twelve healthy adult males, concomitant administration of gemfibrozil (600 mg twice daily) significantly increased the oral ... - Business Wire (press release),

Kos Reports on New Research Presented at AHA: Raising HDL-C or '' ...  Nov 15, 2005
NEJM 2001;345:1583-92 (7) Robins, SJ, Collins D, et al. Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events. ... - Business Wire (press release),

New Data Examines Effects of CRESTOR(R) Alone or in Combination ...  Nov 15, 2005
...risks of this combination. Combination therapy with rosuvastatin and gemfibrozil should generally be avoided. CRESTOR should be ... - Finanzen.net,

No good evidence that cholesterol drugs lower melanoma risk  Nov 10, 2005
The drugs used in various doses in the 16 studies were lovastatin, pravastatin, simvastatin, bezafibrate, clofibrate and gemfibrozil. ... - Dominican Today,

Muraglitazar increases the risk for morbidity and mortality in ...  Oct 23, 2005
...have been introduced. Examples of PPAR-alpha agents include the fibric acid derivatives Fenofibrate and Gemfibrozil. These agents ... - Xagena.it,

Drug Treatments: Making the Right Choice  Sep 24, 2005
Available drugs that can raise HDL either tend to cause unpleasant side effects (eg, niacin) or do not really raise HDL very much (eg, gemfibrozil, or Lopid). ... - Newsweek

Anorectics on Trial: A Half Century of Federal Regulation of ...  Sep 6, 2005
P, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment ... - Annals of Internal Medicine

VNA Health Care Receives $50,000 Donation Through the CRESTOR(R) ...  Aug 27, 2005
...risks of this combination. Combination therapy with rosuvastatin and gemfibrozil should generally be avoided. CRESTOR should be ... - PR Newswire (press release),

Omega-3 fatty acids better than statins in reducing death  Aug 11, 2005
Fibrates are a group of cholesterol-moderating drugs in use since the early 1960s that includes clofibrate (Atromid), gemfibrozil (Lopid), and fenofibrate ... - Health Sentinel

Genesys Regional Medical Center Receives $50,000 Donation Through ...  Jul 30, 2005
...risks of this combination. Combination therapy with rosuvastatin and gemfibrozil should generally be avoided. CRESTOR should be ... - FinanzNachrichten.de

Advisory - Health Canada advises consumers about important safety ...  Jul 12, 2005
...regularly drink three or more alcoholic drinks daily; - are taking other cholesterol lowering medication such as fibrates (gemfibrozil, fenofibrate) or niacin ... - Canada NewsWire (press release) <**results**>

Nicotinic Acid in the Management of Dyslipidaemia Associated With ...  Jun 11, 2005
Analysis of data from VA-HIT showed that the reduction in coronary events with gemfibrozil was greater in patients with insulin resistance (both diabetic and ... - RedNova.com

Emphasis Switches To Good Cholesterol  Jul 5, 2005
...triglycerides. The fibrates, including gemfibrozil (Lopid) and fenofibrate (Tricor and Lofibra), raise HDL by 10 percent to 15 percent. ... - The Ledger

Insights on cholesterol may save more lives  Jul 4, 2005
...triglycerides. The fibrates, including gemfibrozil (Lopid) and fenofibrate (Tricor and Lofibra), raise HDL by 10 percent to 15 percent. - Charlotte Observer

World Congress on the Insulin Resistance Syndrome  Jun 13, 2005
Analyzing the mechanism of gemfibrozil's benefit in the prevention of atherosclerosis in the Veterans' Administration HDL Intervention Trial, Sander Robins, MD ... - Medscape (subscription)

Let's Protect Others from Life-threatening Diseases  Jun 17, 2005
It was later discovered that this drug damages muscles and sometimes can be fatal when used with another drug named Gemfibrozil. ... - AllAfrica.com,

Nicotinic Acid in the Management of Dyslipidaemia Associated With ...  Jun 11, 2005
Analysis of data from VA-HIT showed that the reduction in coronary events with gemfibrozil was greater in patients with insulin resistance (both diabetic and ... - RedNova.com,

World Congress on the Insulin Resistance Syndrome  Jun 13, 2005
Analyzing the mechanism of gemfibrozil's benefit in the prevention of atherosclerosis in the Veterans' Administration HDL Intervention Trial, Sander Robins, MD ... - Medscape (subscription)

Let's Protect Others from Life-threatening Diseases  Jun 17, 2005
It was later discovered that this drug damages muscles and sometimes can be fatal when used with another drug named Gemfibrozil. ... - AllAfrica.com,

FDA Safety Labeling Changes: Crestor, Diamox Sequels, Femring  Jun 8, 2005
...with fibrates or niacin. Combination therapy with rosuvastatin and gemfibrozil generally should be avoided. The risk of myopathy ... - Medscape (subscription)

New Study on Effects of Crestor on Carotid Atherosclerosis ...  Apr 25, 2005
...risks of this combination. Combination therapy with rosuvastatin and gemfibrozil should generally be avoided. CRESTOR should be ... - Medical News Today

Public Citizen: Statin-Associated Rhabdomyolysis  Apr 6, 2005
1. Chang JT, Staffa JA, Parks M, Green L. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. ... - PharmaLive.com

Taking liver-taxing drugs calls for periodic testing  Apr 5, 2005
Zarontin), felbamate (Felbatol), fenofibrate (Tricor), fluconazole (Diflucan), flutamide (Eulexin), fluvastatin (Lescol), gemfibrozil (Lopid), gemtuzumab ... - Contra Costa Times,

Study Showed VYTORIN-TM- -ezetimibe/simvastatin- Superior to ...  Mar 8, 2005
Gemfibrozil: In a study of twelve healthy adult males, concomitant administration of gemfibrozil (600 mg twice daily) significantly increased the oral ... - Business Wire (press release),

Public Advisory - Health Canada Endorsed Important Safety ...  Mar 11, 2005
...muscle pain or muscle weakness while using a "statin" drug - Taking other cholesterol-lowering medication such as fibrates (gemfibrozil, fenofibrate) or niacin ... - Canada NewsWire (press release),

‘Good’ cholesterol boost helps arteries  Mar 13, 2005
The latest: This study randomly assigned 143 retirees with low HDL levels and narrowed arteries to take a combination of gemfibrozil, niacin and cholestyramine ... - Nashua Telegraph,

Astrazeneca Presents New Data Demonstrating Crestor® Reduced C ...  Mar 9, 2005
...risks of this combination. Combination therapy with rosuvastatin and gemfibrozil should generally be avoided. CRESTOR should be ... - Medical News Today,

FDA MedWatch - FDA Public Health Advisory issued for Crestor ...  Mar 2, 2005
The maximum recommended dose in the FDA-approved label is limited to 10 mg daily in patients with severe renal impairment or who are also taking gemfibrozil. ... - PharmaLive.com (press release),

Class action spring cleaning on Moran's docket  Feb 16, 2005
...claimed the companies deceptively advertised Baycol, a drug to reduce cholesterol, and concealed the danger of taking it with another drug, gemfibrozil. ... - Madison County Record,

Update on Risk Factors for Atherosclerosis: The Role of ...  Feb 26, 2005
Fibric acid derivatives (gemfibrozil [Lopid], fenofibrate [Tricor], clofibrate [Abitrate]) are used to decrease triglyceride levels. ... - RedNova.com,

BCBSNC Launches New Prescription Drug Savings Initiative  Feb 17, 2005
...generic Paxil) trazodone (generic Desyrel) LIPID-LOWERING AGENTS (Drugs to Treat High Cholesterol) cholestyramine (generic Questran) gemfibrozil (generic Lopid ... - PR Newswire (press release)

Dosage Forms CAPSULE; TABLET
Drug_Category Antilipemic Agents; Fribic Acid Derivatives; ATC:C10AB04
Absorption Well absorbed from GI after oral administration (within 1-2 hours)
Interactions -->Interactions for Gemfibrozil:
)
 
 Clinical Laboratory
 

increased creatine

positive antinuclear

 

phosphokinase

antibody

 

increased bilirubin

 
 

increased liver

 
 

transaminases (AST

 
 

(SGOT), ALT (SGPT)

 
 

increased alkaline

 
 

phophatase

 
 Hematopoietic

anemia

thrombocytopenia

 

leukopenia

 
 

bone marrow hypoplasia

 
 

eosinophilia

 
 Immunologic

angioedema

anaphylaxis

 

laryngeal edema

Lupus-like syndrome

 

urticaria

vasculitis

 Integumentary

exfoliative dermatitis

alopecia

 

rash

 
 

dermatitis

 
 

pruritus

 


Toxicity Overdoses lead to abdominal cramps, abnormal liver function tests, diarrhea, increased CPK, joint and muscle pain, nausea and vomiting, LD50=3162mg/kg (orally in mice)
Organisms Affected Humans and other mammals
Chemical IUPAC Name 5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid
Chemical Formula C15H22O3
Molecular Weight 250.333 g/mol
Smiles String CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
Melting Point 61-63°C
Water Solubility 10 mg/mL (in base)
State Solid
LogP/Hphobicity 4.242
Isoelectric Point Not Available
Biotransformation Hepatic
Half Life 1.5 hours
Protein Binding [%] 95%
RxList Link RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Gemfibrozil.html
http://www.rxlist.com/cgi/generic/gemfib.htm
http://www.pharmgkb.org/views/index.jsp?objId=
Drug Type Approved Drug
Accession No APRD00293
CAS Registry Number 25812-30-0
KEGG Compound ID D00334
PubChem ID SID:175056
PharmGKB ID PA449750
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] 2241608

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org